Press Releases

Read our latest announcements

Filter by year:

2017-02-20
Modus Therapeutics raises SEK 32 million to support further development of sevuparin for sickle cell disease

STOCKHOLM, SWEDEN – 20 February, 2017. Modus Therapeutics AB, a Karolinska Development (STO:KDEV) portfolio company focused on innovative treatments for patients with sickle cell disease, announces the successful completion of a financing round raising SEK 32 million from existing investors KDev Investments, Östersjöstiftelsen and Praktikerinvest.  Modus Therapeutics is currently recruiting patients in Europe, the Middle East and […]

View Press Release